Manchester Financial Inc Abb Vie Inc. Transaction History

Manchester Financial Inc

$433 Million
Q3 2024

A detailed history of Manchester Financial Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Manchester Financial Inc holds 4,547 shares of ABBV stock, worth $818,460. This represents 0.21% of its overall portfolio holdings.

Number of Shares

4,547

Previous 4,514 0.73%

Holding current value

$818,460

Previous $774,000 15.89%

% of portfolio

0.21%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $5,406 - $6,577	33 Added 0.73%	4,547 $897,000
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $15,788 - $18,437	102 Added 2.31%	4,514 $774,000
Q1 2024 Apr 18, 2024	BUY	$159.82 - $182.1 $24,931 - $28,407	156 Added 3.67%	4,412 $803,000
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $24,630 - $27,739	-179 Reduced 4.04%	4,256 $659,000
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $14,828 - $17,166	-111 Reduced 2.44%	4,435 $661,000
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $1,987 - $2,473	-15 Reduced 0.33%	4,546 $612,000
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $10,122 - $11,657	-70 Reduced 1.51%	4,561 $726,000
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $37,758 - $45,282	-273 Reduced 5.57%	4,631 $748,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $9,260 - $10,621	-69 Reduced 1.39%	4,904 $658,000
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $4,403 - $5,598	-32 Reduced 0.64%	4,973 $762,000
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $281,909 - $349,770	-2,136 Reduced 29.91%	5,005 $811,000
Q4 2021 Feb 03, 2022	BUY	$107.43 - $135.93 $67,036 - $84,820	624 Added 9.57%	7,141 $967,000
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $31,707 - $35,992	298 Added 4.79%	6,517 $703,000
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $365,920 - $407,656	3,478 Added 126.89%	6,219 $701,000
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $98,003 - $107,889	958 Added 53.73%	2,741 $297,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $9,417 - $12,714	117 Added 7.02%	1,783 $191,000
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $28,522 - $33,475	332 Added 24.89%	1,666 $146,000
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $1,834 - $2,454	25 Added 1.91%	1,334 $131,000
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $9,352 - $14,179	-145 Reduced 9.97%	1,309 $100,000
Q4 2019 Jan 17, 2020	BUY	$72.13 - $90.25 $104,877 - $131,223	1,454 New	1,454 $129,000
Q3 2019 Oct 09, 2019	SELL	$62.98 - $75.72 $93,777 - $112,747	-1,489 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $97,827 - $125,046	1,489 New	1,489 $108,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Financial Inc with notifications on news.

Account

Manchester Financial Inc Abb Vie Inc. Transaction History